UK targets hepatitis C detection:
This article was originally published in Clinica
Executive Summary
A hepatitis C public health campaign has been launched in England, with the main aim of encouraging testing to help detect the more than 100,000 cases thought to remain undiagnosed. The "FaCe It" campaign will run for two years and will be aimed particularly at those people who are, or have been, at higher risk of contracting the hepatitis C virus (HCV), in order to advise them about getting tested. There are approximately 200,000 people chronically infected from HCV, yet the majority of these are unaware of their infection, says the Department of Health. The value of testing for this chronic disease is that it is largely asymptomatic and can develop into potentially serious conditions, yet is responsive to treatment in about 55% of cases.
You may also be interested in...
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.